Zobrazeno 1 - 10
of 149
pro vyhledávání: '"H. Mameghan"'
Autor:
H. Mameghan, N. K. Gogna, J. Keller, G. M. Duchesne, J. H. L. Matthews, S. L. Turner, N. Spry, M. P. Berry, L. Tripcony
Publikováno v:
Australasian Radiology. 50:A55-A69
Background Several Phase II studies of cisplatin based concurrent chemoradiation have suggested that this approach is better than radiation alone in the management of muscle invasive TCC of the Urinary Bladder. Thus far, there is no widely accepted s
Autor:
P. Zelas, E. L. Bokey, P. Yuile, Pierre H. Chapuis, E. Galt, Owen F. Dent, H. Mameghan, M. Nicholls
Publikováno v:
ANZ Journal of Surgery. 66:680-685
Backgrounds and Methods: This study reviews the clinical features and reports the preliminary results of treatment of 34 consecutive patients with clinically significant bleeding from chronic, radiation-induced proctitis, using a combination of endos
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 32:839-846
Purpose : To measure the dose received by the unshielded testes during a conventional course of 18 MV photon radiotherapy for localized prostate cancer and to identify the factors influencing it. Methods and Materials : For each of four patients, a w
Autor:
T. F. Sandeman, H. Mameghan
Publikováno v:
ANZ Journal of Surgery. 61:173-178
Since 1968, studies have been conducted in Australia and New Zealand to improve the results of treatment for invasive bladder cancer. The prognostic value of clinical stage and of ureteric obstruction has been confirmed. Radiotherapy has been establi
Autor:
J, Beilin, L, Harewood, M, Frydenberg, H, Mameghan, R F, Martyres, S J, Farish, C, Yue, D R, Deam, K A, Byron, J D, Zajac
Publikováno v:
Cancer. 92(4)
The development of prostate carcinoma is androgen-dependent. The coding sequence of the androgen receptor (AR) gene contains a CAG repeat polymorphism that has been shown to influence AR activity in vitro. Studies of this polymorphism as a prostate c
Autor:
M, Frydenberg, G G, Giles, H, Mameghan, V J, Thursfield, J, Millar, J B, Wheelahan, D M, Bolton, R R, Syme
Publikováno v:
The Medical journal of Australia. 172(6)
To describe the management of newly diagnosed prostate cancer in 1993 during the early prostate specific antigen (PSA) era.Survey of medical practitioners involved in the management of a total sample of incident prostate cancer cases selected from a
Autor:
Richard F. Kefford, Bull Ca, William H. McCarthy, Graham Stevens, Mark A. Rosenthal, H. Mameghan, Alan S. Coates
Publikováno v:
European Journal of Cancer and Clinical Oncology. 27:1564-1566
In two pilot studies, 55 patients with symptomatic metastases from malignant melanoma were treated with irradiation and concurrent cisplatin. In the first group, cisplatin was given as a continuous intravenous infusion of 20 mg/m2 per day on days 1-5
Autor:
H, Mameghan
Publikováno v:
Australian family physician. 28(8)
Each year over 12,000 men are diagnosed with prostate cancer in Australia and there is an increasing need to keep up with a reasonable knowledge of the disease for day to day patient management.To summarise the main issues in prostate cancer screenin
Autor:
A R, Barnetson, D, Banasiak, R J, Fisher, H, Mameghan, J C, Ribeiro, K, Brown, J L, Brown, S M, O'Mara, P J, Russell
Publikováno v:
Radiation oncology investigations. 7(2)
Human bladder cancer is often heterogeneous containing biologically different populations. Radiotherapy plus chemotherapy is the most common treatment for invasive disease. However few studies have investigated the role of heterogeneity in determinin
Publikováno v:
Radiation oncology investigations. 7(2)
Using a series of human bladder cancer cell lines and an immortalised normal ureteral cell line, radiosensitivities measured by three different methods after a single dose of X-radiation are compared. Clear differences between cell survival curves ob